NO993774L - Karbapenem-forbindelse, anvendelse herav og intermediær forbindelse herav - Google Patents

Karbapenem-forbindelse, anvendelse herav og intermediær forbindelse herav

Info

Publication number
NO993774L
NO993774L NO993774A NO993774A NO993774L NO 993774 L NO993774 L NO 993774L NO 993774 A NO993774 A NO 993774A NO 993774 A NO993774 A NO 993774A NO 993774 L NO993774 L NO 993774L
Authority
NO
Norway
Prior art keywords
diseases
infectious diseases
prophylaxis
agents
treatment
Prior art date
Application number
NO993774A
Other languages
English (en)
Norwegian (no)
Other versions
NO993774D0 (no
Inventor
Hiroshi Matsui
Masayasu Kasai
Original Assignee
Kyoto Pharma Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyoto Pharma Ind filed Critical Kyoto Pharma Ind
Publication of NO993774D0 publication Critical patent/NO993774D0/no
Publication of NO993774L publication Critical patent/NO993774L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
NO993774A 1997-02-07 1999-08-04 Karbapenem-forbindelse, anvendelse herav og intermediær forbindelse herav NO993774L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2567197 1997-02-07
JP24890397 1997-09-12
PCT/JP1998/000446 WO1998034936A1 (fr) 1997-02-07 1998-02-02 Composes de carbapenem, leur utilisation et composes intermediaires de celui-ci

Publications (2)

Publication Number Publication Date
NO993774D0 NO993774D0 (no) 1999-08-04
NO993774L true NO993774L (no) 1999-09-30

Family

ID=26363329

Family Applications (1)

Application Number Title Priority Date Filing Date
NO993774A NO993774L (no) 1997-02-07 1999-08-04 Karbapenem-forbindelse, anvendelse herav og intermediær forbindelse herav

Country Status (23)

Country Link
US (1) US6342494B1 (cs)
EP (1) EP0987267B1 (cs)
KR (1) KR100530478B1 (cs)
CN (1) CN1107067C (cs)
AT (1) ATE239728T1 (cs)
AU (1) AU740327C (cs)
BG (1) BG63974B1 (cs)
BR (1) BR9807187A (cs)
CA (1) CA2280273A1 (cs)
CZ (1) CZ272099A3 (cs)
DE (1) DE69814381T2 (cs)
ES (1) ES2198689T3 (cs)
HU (1) HUP0000952A3 (cs)
ID (1) ID22543A (cs)
NO (1) NO993774L (cs)
NZ (1) NZ337532A (cs)
PL (1) PL335048A1 (cs)
RU (1) RU2178792C2 (cs)
SK (1) SK108099A3 (cs)
TR (1) TR199901887T2 (cs)
TW (1) TW580499B (cs)
WO (1) WO1998034936A1 (cs)
YU (1) YU37299A (cs)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA03010607A (es) * 2001-05-21 2004-04-02 Kyoto Pharma Ind Compuesto de carbapenem.
WO2003040146A1 (fr) 2001-11-05 2003-05-15 Sumitomo Pharmaceuticals Co., Ltd. Nouveaux composes carbapenem
US7468364B2 (en) * 2003-04-08 2008-12-23 Dainippon Sumitomo Pharma Co., Ltd. Carbapenem compounds
WO2006025475A1 (ja) * 2004-09-03 2006-03-09 Dainippon Sumitomo Pharma Co., Ltd. 新規なカルバペネム化合物
WO2006103999A1 (ja) * 2005-03-25 2006-10-05 Dainippon Sumitomo Pharma Co., Ltd. 新規なカルバペネム化合物
KR100869165B1 (ko) 2007-09-13 2008-11-19 조동옥 메로페넴의 개선된 제조방법
US20110118229A1 (en) * 2007-11-23 2011-05-19 Kukje Pharm. Ind. Co., Ltd. 2-arylmethylazetidine-carbapenem-3-carboxylic acid ester derivative or its salt, process for the preparation thereof and pharmaceutical composition comprising the same
CN103504481A (zh) * 2013-10-11 2014-01-15 红塔烟草(集团)有限责任公司 一种带抗菌层烟嘴的电子卷烟

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1283906C (en) 1983-05-09 1991-05-07 Makoto Sunagawa .beta.-LACTAM COMPOUNDS AND PRODUCTION THEREOF
JPS60202886A (ja) * 1984-03-27 1985-10-14 Sankyo Co Ltd 1―置換カルバペネム―3―カルボン酸誘導体
DE3579888D1 (de) * 1984-11-08 1990-10-31 Sumitomo Pharma Carbapenemverbindungen und deren herstellung.
JPS61275279A (ja) * 1984-12-25 1986-12-05 Sankyo Co Ltd カルバペネム化合物
IE60588B1 (en) * 1986-07-30 1994-07-27 Sumitomo Pharma Carbapenem compound in crystalline form, and its production and use
AU644008B2 (en) * 1990-08-10 1993-12-02 Sumitomo Pharmaceuticals Company, Limited Beta-lactam compounds, and their production and use
US5712267A (en) * 1991-06-04 1998-01-27 Sankyo Company,. Limited Carbapenem derivatives, their preparation and their use as antibiotics
US5360798A (en) * 1991-07-04 1994-11-01 Shionogi Seiyaku Kabushiki Kaisha Aminooxypyrrolidinylthiocarbapenem compounds
NO304981B1 (no) * 1992-09-09 1999-03-15 Sankyo Co FremgangsmÕte for fremstilling av karbapenem- og penemforbindelser, samt nye forbindelser involvert i fremgangsmÕten
KR100386993B1 (ko) 1995-12-21 2003-12-18 상꾜 가부시키가이샤 1-메틸카르바페넴유도체
JP3671529B2 (ja) 1996-07-29 2005-07-13 ソニー株式会社 熱転写形記録装置及び記録方法

Also Published As

Publication number Publication date
CZ272099A3 (cs) 1999-11-17
BG103699A (en) 2000-06-30
KR20000070809A (ko) 2000-11-25
NO993774D0 (no) 1999-08-04
EP0987267B1 (en) 2003-05-07
ES2198689T3 (es) 2004-02-01
AU5680698A (en) 1998-08-26
EP0987267A1 (en) 2000-03-22
EP0987267A4 (en) 2000-05-31
HUP0000952A2 (hu) 2000-10-28
YU37299A (sh) 2002-06-19
TR199901887T2 (xx) 1999-12-21
SK108099A3 (en) 2000-03-13
RU2178792C2 (ru) 2002-01-27
CN1252072A (zh) 2000-05-03
HK1026896A1 (en) 2000-12-29
DE69814381D1 (de) 2003-06-12
PL335048A1 (en) 2000-03-27
KR100530478B1 (ko) 2005-11-23
BG63974B1 (bg) 2003-08-29
ATE239728T1 (de) 2003-05-15
ID22543A (id) 1999-11-04
HUP0000952A3 (en) 2000-12-28
CN1107067C (zh) 2003-04-30
US6342494B1 (en) 2002-01-29
DE69814381T2 (de) 2003-12-04
NZ337532A (en) 2001-06-29
BR9807187A (pt) 2000-01-25
WO1998034936A1 (fr) 1998-08-13
AU740327C (en) 2002-05-09
AU740327B2 (en) 2001-11-01
CA2280273A1 (en) 1998-08-13
TW580499B (en) 2004-03-21

Similar Documents

Publication Publication Date Title
ATE247972T1 (de) Pulmonare abgabe von protonierter/angesäuerter nukleinsäure
PT1235826E (pt) Acrilamidas de quinuclidina
DE60117861D1 (de) Antimikrobielle chinolonderivate und ihre verwendung zur behandlung bakterieller infektionen
CY1108437T1 (el) Φαρμακοτεχνικες μορφες οι οποιες περιεχουν μια ενωση κεφαλοσπορινης και η χρηση τους στη θεραπεια βακτηριακων λοιμωξεων σε γατους και σκυλους
CY1106977T1 (el) Χρησιμοποιηση παραγωγων χινολονης και χινολιζινονης σαν χημειοθεραπευτικα
TR200001330T2 (tr) Oksazolidinon türevleri ve farmasötik terkipler
ATE496048T1 (de) Phenylcarboxamidverbindungen zur schmerzbehandlung
RU94008616A (ru) 2-тиозамещенные карбапенемы, промежуточные соединения для получения, способы получения, фармацевтическая композиция, способ лечения бактериальных инфекций
NO993774D0 (no) Carbapenem-forbindelse, anvendelse herav og intermediær forbindelse herav
DE60035429D1 (de) Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen
HRP20050517B1 (hr) N-sulfonil-4-metilenamino-3-hidroksi-2-piridoni kao antimikrobni lijekovi
DE60018186D1 (de) Arzneimittel zur vorbeugung / behandlung / inhibierung des fortschritts für einfache oder preproliferative retinopathie
BR9915639A (pt) Uso de derivados de ácido fosfonofórmico para o tratamento de infecções
ES2113391T3 (es) Factor c2a de antibiotico ge 2270.
NZ503145A (en) 8a-Azalides as veterinary antimicrobial agents to treat bacterial respiratory infection
DK0675900T3 (da) Antibiotika GE 37468 A, B og C
BR9915605A (pt) Uso de derivados do ácido fosfonofórmico para o tratamento de infecções
TH36001A (th) สารประกอบคาร์บาเพเนม การใช้ประโยชน์ของมัน และสารประกอบมัธยันตร์ของมัน
DK1196439T3 (da) Forbindelser udvisende en antibiotikaaktivitet
NO20013464L (no) Anvendelse av 3-isoksazolidinoner og hydroksylaminsyrer for behandling av infeksjoner
BR0215070A (pt) Métodos de tratamento de infecções bacterianas em cães e gatos
AP1684A (en) Dithiocarbamate derivatives and their use as antibacterial agents.
UA37648A (uk) Спосіб лікування респіраторних захворювань у телят

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application